Come up with a name for your new list and we'll add to it:
Biorg raised a round of funding on January 19, 2017. Investors include
North Carolina Biotechnology Center.
Biorg is developing a liver cancer model for drug safety and efficacy testing that promises improved predictive accuracy and reduced reliance on animal testing. The Biorg system can test drugs using h…